What is the intrinsic value of ADXN.SW?

As of 2025-05-17, the Intrinsic Value of Addex Therapeutics Ltd (ADXN.SW) is 0.15 CHF. This ADXN.SW valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.06 CHF, the upside of Addex Therapeutics Ltd is 164.60%.

Is ADXN.SW undervalued or overvalued?

Based on its market price of 0.06 CHF and our intrinsic valuation, Addex Therapeutics Ltd (ADXN.SW) is undervalued by 164.60%.

	Range	Selected	Upside
a
DCF (Growth 5y)	(12.34) - (1.09)	(1.98)	-3677.3%
DCF (Growth 10y)	(1.09) - (11.59)	(1.92)	-3574.2%
DCF (EBITDA 5y)	(0.37) - (0.43)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(0.47) - (0.55)	(1,234.50)	-123450.0%
Fair Value	0.15 - 0.15	0.15	164.60%
P/E	0.26 - 0.41	0.31	458.3%
EV/EBITDA	(0.19) - (0.20)	(0.20)	-464.8%
EPV	(1.11) - (1.49)	(1.30)	-2450.8%
DDM - Stable	0.70 - 14.11	7.41	13273.6%
DDM - Multi	(0.93) - (14.66)	(1.76)	-3278.2%